Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Steven Kyle Grinspoon, M.D.

Co-Author

This page shows the publications co-authored by Steven Grinspoon and Martin Torriani.
Connection Strength

6.766
  1. Dysfunctional Subcutaneous Fat With Reduced Dicer and Brown Adipose Tissue Gene Expression in HIV-Infected Patients. J Clin Endocrinol Metab. 2016 Mar; 101(3):1225-34.
    View in: PubMed
    Score: 0.647
  2. Increased FDG uptake in association with reduced extremity fat in HIV patients. Antivir Ther. 2013; 18(2):243-8.
    View in: PubMed
    Score: 0.516
  3. Deiodinase 2 expression is increased in dorsocervical fat of patients with HIV-associated lipohypertrophy syndrome. J Clin Endocrinol Metab. 2012 Apr; 97(4):E602-7.
    View in: PubMed
    Score: 0.491
  4. Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution. J Appl Physiol (1985). 2006 Feb; 100(2):609-14.
    View in: PubMed
    Score: 0.318
  5. Racial differences in fat distribution: the importance of intermuscular fat. Am J Clin Nutr. 2005 Apr; 81(4):731-2.
    View in: PubMed
    Score: 0.306
  6. Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with the HIV-lipodystrophy syndrome. J Appl Physiol (1985). 2003 Sep; 95(3):1005-10.
    View in: PubMed
    Score: 0.269
  7. Altered pattern of circulating miRNAs in HIV lipodystrophy perturbs key adipose differentiation and inflammation pathways. JCI Insight. 2021 09 22; 6(18).
    View in: PubMed
    Score: 0.240
  8. Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease. Clin Infect Dis. 2021 08 16; 73(4):621-630.
    View in: PubMed
    Score: 0.238
  9. Clinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease. Clin Infect Dis. 2021 06 15; 72(12):2087-2094.
    View in: PubMed
    Score: 0.236
  10. Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach. Sci Rep. 2021 05 18; 11(1):10485.
    View in: PubMed
    Score: 0.234
  11. Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease. J Clin Endocrinol Metab. 2021 01 23; 106(2):e520-e533.
    View in: PubMed
    Score: 0.229
  12. Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD. JCI Insight. 2020 08 20; 5(16).
    View in: PubMed
    Score: 0.223
  13. Brief Report: Adipogenic Expression of Brown Fat Genes in HIV and HIV-Related Parameters. J Acquir Immune Defic Syndr. 2019 12 15; 82(5):491-495.
    View in: PubMed
    Score: 0.212
  14. Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial. Lancet HIV. 2019 12; 6(12):e821-e830.
    View in: PubMed
    Score: 0.210
  15. Comparison of visceral fat measurement by dual-energy X-ray absorptiometry to computed tomography in HIV and non-HIV. Nutr Diabetes. 2019 02 25; 9(1):6.
    View in: PubMed
    Score: 0.201
  16. Relationship of visceral and subcutaneous adipose depots to markers of arterial injury and inflammation among individuals with HIV. AIDS. 2019 02 01; 33(2):229-236.
    View in: PubMed
    Score: 0.200
  17. Significant Association of Aldosterone and Liver Fat Among HIV-Infected Individuals With Metabolic Dysregulation. J Endocr Soc. 2018 Oct 01; 2(10):1147-1157.
    View in: PubMed
    Score: 0.194
  18. Randomized, Placebo-Controlled Trial to Evaluate Effects of Eplerenone on Metabolic and Inflammatory Indices in HIV. J Clin Endocrinol Metab. 2018 06 01; 103(6):2376-2384.
    View in: PubMed
    Score: 0.191
  19. Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized Trial. J Clin Endocrinol Metab. 2016 Mar; 101(3):1123-33.
    View in: PubMed
    Score: 0.161
  20. RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients. J Clin Endocrinol Metab. 2015 Aug; 100(8):2873-82.
    View in: PubMed
    Score: 0.155
  21. Effects of lifestyle modification and metformin on irisin and FGF21 among HIV-infected subjects with the metabolic syndrome. Clin Endocrinol (Oxf). 2015 May; 82(5):678-85.
    View in: PubMed
    Score: 0.148
  22. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial. JAMA. 2014 Jul 23-30; 312(4):380-9.
    View in: PubMed
    Score: 0.145
  23. Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial. J Clin Endocrinol Metab. 2012 Dec; 97(12):4769-79.
    View in: PubMed
    Score: 0.129
  24. Effects of lifestyle modification and metformin on atherosclerotic indices among HIV-infected patients with the metabolic syndrome. AIDS. 2012 Mar 13; 26(5):587-97.
    View in: PubMed
    Score: 0.124
  25. Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome. Am J Physiol Endocrinol Metab. 2007 Jul; 293(1):E102-9.
    View in: PubMed
    Score: 0.088
  26. Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults. Am J Physiol Endocrinol Metab. 2007 Jun; 292(6):E1666-73.
    View in: PubMed
    Score: 0.087
  27. Improved triglycerides and insulin sensitivity with 3 months of acipimox in human immunodeficiency virus-infected patients with hypertriglyceridemia. J Clin Endocrinol Metab. 2006 Nov; 91(11):4438-44.
    View in: PubMed
    Score: 0.084
  28. Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy. Am J Physiol Endocrinol Metab. 2006 Feb; 290(2):E289-98.
    View in: PubMed
    Score: 0.079
  29. Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial. JAMA. 2004 Jul 14; 292(2):210-8.
    View in: PubMed
    Score: 0.073
  30. Differential effects of metformin and exercise on muscle adiposity and metabolic indices in human immunodeficiency virus-infected patients. J Clin Endocrinol Metab. 2004 May; 89(5):2171-8.
    View in: PubMed
    Score: 0.072
  31. Measures of Adipose Tissue Redistribution and Atherosclerotic Coronary Plaque in HIV. Obesity (Silver Spring). 2020 04; 28(4):749-755.
    View in: PubMed
    Score: 0.054
  32. Effects of Pitavastatin on Insulin Sensitivity and Liver Fat: A Randomized Clinical Trial. J Clin Endocrinol Metab. 2018 11 01; 103(11):4176-4186.
    View in: PubMed
    Score: 0.049
  33. Excessive Adiposity and Metabolic Dysfunction Relate to Reduced Natriuretic Peptide During RAAS Activation in HIV. J Clin Endocrinol Metab. 2018 04 01; 103(4):1558-1565.
    View in: PubMed
    Score: 0.047
  34. Fibroblast growth factor 21 decreases after liver fat reduction via growth hormone augmentation. Growth Horm IGF Res. 2017 12; 37:1-6.
    View in: PubMed
    Score: 0.046
  35. Altered miRNA processing disrupts brown/white adipocyte determination and associates with lipodystrophy. J Clin Invest. 2014 Aug; 124(8):3339-51.
    View in: PubMed
    Score: 0.036
  36. Effects of exercise and lifestyle modification on fitness, insulin resistance, skeletal muscle oxidative phosphorylation and intramyocellular lipid content in obese children and adolescents. Pediatr Obes. 2014 Aug; 9(4):281-91.
    View in: PubMed
    Score: 0.034
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.